Bio-Techne Corp (TECH)

Current ratio

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Total current assets	US$ in thousands	617,419	610,650	590,640	591,477	621,482	570,996	565,183	552,031	605,556	593,108	590,230	543,748	510,606	566,606	541,933	541,893	520,920	491,928	465,074	391,945
Total current liabilities	US$ in thousands	159,379	149,820	135,231	127,754	128,509	141,163	128,395	137,629	176,018	166,838	154,809	133,992	152,284	137,640	117,568	105,424	106,668	104,985	104,953	88,268
Current ratio		3.87	4.08	4.37	4.63	4.84	4.04	4.40	4.01	3.44	3.55	3.81	4.06	3.35	4.12	4.61	5.14	4.88	4.69	4.43	4.44

June 30, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $617,419K ÷ $159,379K
= 3.87

The current ratio of Bio-Techne Corp has shown fluctuation over the past few quarters, averaging around 4. This indicates that the company has consistently maintained a strong ability to cover its short-term liabilities with its current assets. The ratio has generally remained well above 2, which is considered a healthy level for most companies.

The fluctuations in the current ratio could be due to changes in the company's current assets and liabilities over time. A higher current ratio suggests that Bio-Techne Corp has a larger buffer to meet its short-term obligations, which indicates good liquidity and financial health. However, it is worth noting that a very high current ratio could also indicate that the company is not efficiently managing its current assets.

Overall, the consistent current ratio above 2 and the average around 4 indicate that Bio-Techne Corp has maintained a solid liquidity position and has the ability to meet its short-term obligations comfortably.